Q1 2025 · 13F-HR
DIADEMA PARTNERS LPholdings as filed
Filed 2025-05-15 · accession 0001892688-25-000116
$383.3M
Reported value
102
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 031162100 | AMGN | AMGEN INC | $32.2M | 8.40% | 103,300 | CALL | SOLE |
| 717081103 | PFE | PFIZER INC | $22.8M | 5.95% | 900,000 | CALL | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $18.9M | 4.94% | 29,828 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $17.2M | 4.48% | 150,200 | PUT | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $17.1M | 4.46% | 20,700 | PUT | SOLE |
| 031162100 | AMGN | AMGEN INC | $16.2M | 4.24% | 52,100 | PUT | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $15.9M | 4.16% | 19,302 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $15.7M | 4.09% | 219,400 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $15.5M | 4.05% | 217,000 | PUT | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $12.7M | 3.31% | 20,000 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $10.8M | 2.82% | 87,189 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $8.8M | 2.29% | 70,800 | CALL | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $8.7M | 2.26% | 124,600 | PUT | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $8.3M | 2.15% | 10,000 | CALL | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $8.2M | 2.14% | 207,883 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $7.5M | 1.97% | 108,700 | CALL | SOLE |
| 04016X101 | ARGX | ARGENX SE | $7.2M | 1.87% | 12,279 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $6.9M | 1.80% | 62,247 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $6.6M | 1.73% | 93,002 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $5.4M | 1.41% | 20,000 | PUT | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $4.7M | 1.23% | 126,300 | CALL | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $4.6M | 1.19% | 40,000 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $4.5M | 1.19% | 131,400 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.5M | 1.16% | 123,300 | PUT | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.2M | 1.11% | 117,000 | CALL | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $3.8M | 0.99% | 112,000 | CALL | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $3.7M | 0.98% | 52,877 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $3.7M | 0.96% | 698,400 | CALL | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $3.5M | 0.92% | 13,115 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $3.5M | 0.92% | 119,700 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $3.5M | 0.91% | 92,385 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $2.9M | 0.75% | 96,984 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $2.8M | 0.74% | 100,000 | PUT | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.6M | 0.69% | 50,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.6M | 0.69% | 60,000 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $2.6M | 0.68% | 519,900 | CALL | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.5M | 0.66% | 104,121 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.4M | 0.62% | 164,048 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $2.3M | 0.61% | 392,213 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $2.2M | 0.57% | 162,063 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $2.2M | 0.57% | 117,300 | PUT | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $2.2M | 0.56% | 98,200 | CALL | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $2.1M | 0.56% | 179,300 | CALL | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $2.1M | 0.55% | 418,800 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.9M | 0.51% | 51,600 | PUT | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.9M | 0.49% | 57,923 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $1.8M | 0.47% | 96,800 | CALL | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.7M | 0.44% | 231,436 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $1.7M | 0.44% | 24,618 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.6M | 0.43% | 154,100 | CALL | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.6M | 0.41% | 135,509 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.5M | 0.39% | 147,100 | CALL | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $1.5M | 0.39% | 40,000 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $1.5M | 0.39% | 52,100 | CALL | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $1.5M | 0.38% | 183,466 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $1.4M | 0.37% | 565,975 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $1.3M | 0.34% | 8,321 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.2M | 0.32% | 50,000 | CALL | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $1.2M | 0.31% | 201,400 | PUT | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.2M | 0.31% | 103,300 | CALL | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.2M | 0.30% | 515,200 | CALL | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $1.1M | 0.30% | 180,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.1M | 0.29% | 426,346 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $1.1M | 0.28% | 131,400 | CALL | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $1.0M | 0.26% | 136,700 | CALL | SOLE |
| 695127100 | PCRX | PACIRA BIOSCIENCES INC | $967,311 | 0.25% | 38,926 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $907,280 | 0.24% | 824,800 | CALL | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $842,993 | 0.22% | 76,220 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $817,160 | 0.21% | 669,803 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $803,800 | 0.21% | 20,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $726,668 | 0.19% | 74,530 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $670,502 | 0.17% | 65,800 | PUT | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $653,434 | 0.17% | 208,100 | CALL | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $620,660 | 0.16% | 650,723 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $601,500 | 0.16% | 50,000 | PUT | SOLE |
| 014442107 | ALEC | ALECTOR INC | $561,552 | 0.15% | 456,546 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $534,233 | 0.14% | 116,900 | CALL | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $476,463 | 0.12% | 24,700 | CALL | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $461,176 | 0.12% | 678,200 | CALL | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $450,000 | 0.12% | 300,000 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $386,900 | 0.10% | 36,500 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $380,000 | 0.10% | 200,000 | CALL | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $376,000 | 0.10% | 100,000 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $362,313 | 0.09% | 170,100 | PUT | SOLE |
| 91381U200 | UNBX | UNITY BIOTECHNOLOGY INC | $360,776 | 0.09% | 346,900 | CALL | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $346,402 | 0.09% | 317,800 | CALL | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $344,268 | 0.09% | 131,400 | CALL | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $296,548 | 0.08% | 269,589 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $287,547 | 0.08% | 30,300 | CALL | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $276,233 | 0.07% | 207,694 | Common | SOLE |
| 91381U200 | UNBX | UNITY BIOTECHNOLOGY INC | $223,808 | 0.06% | 215,200 | PUT | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $219,038 | 0.06% | 64,613 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $168,512 | 0.04% | 492,215 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $165,194 | 0.04% | 54,700 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $154,830 | 0.04% | 56,098 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $150,022 | 0.04% | 46,019 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $141,504 | 0.04% | 25,045 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $88,650 | 0.02% | 39,400 | PUT | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $35,636 | 0.01% | 11,800 | PUT | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $14,850 | 0.00% | 9,900 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $12,415 | 0.00% | 100 | PUT | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $500 | 0.00% | 200 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.